The U.S. lacks a formal notification system for lab leaks, but as of Sunday, new guidelines from the Trump administration mandate that laboratories must make information about genetic engineering research and accidental infections publicly available.
Hundreds of Institutional Biosafety Committees (IBCs) will oversee potential risks associated with research. These committees, based in universities, federal labs, biotechnology firms, and hospitals, evaluate high-risk experiments and review gain-of-function studies—research aimed at making viruses more deadly or contagious. They also assess lab accidents and exposure risks to infectious agents.
Under a new policy from the National Institutes of Health (NIH), the IBC is now required to publish meeting minutes as soon as they are approved by the research institutions.
Overall, NIH expects labs to report significant leaks. Though IBC operations have typically lacked transparency and accountability to federal funders, advocates point out that this is changing.
Historically, requests for IBC meeting minutes were only addressed if made by the public, not provided proactively by research institutions. This limited access has contributed to public uncertainty regarding high-risk research.
Concerns about biosafety have been raised, especially regarding experiments deemed risky. For instance, recent allegations about the University of Southern California’s intentions to conduct hazardous aerosol experiments have emerged, with requests for IBC minutes going unaddressed.
While there’s no official database for lab accidents, available records of IBC meetings could shed light on potential biohazards resulting from laboratory work.
Public access to information about hazardous research is a step forward. However, some experts stress that more needs to be done, particularly in evaluating the necessity of certain risky research projects. Laura Kahn, an author on bioethics and public health, emphasized the need for informed policies to ensure that the benefits of research outweigh the potential risks.
NIH Director Jay Bhattacharya has initiated a new interagency process aimed at enhancing guidance around gain-of-function research, which many view as a critical area for regulation.
Bhattacharya has expressed concerns that ongoing research might unintentionally lead to future pandemics. He encourages researchers and institutions to critically evaluate their experiments, especially those involving potentially harmful viruses.
Ultimately, there’s a call for universities and organizations to recognize the dangers presented by such research and to engage in stringent regulatory practices to mitigate risks.
